WallStreetZenWallStreetZen

NASDAQ: CMMB
Chemomab Therapeutics Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CMMB earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$24.2M
Current Profit Margin
0%

CMMB Return on Equity

Current Company
-114%
Current Industry
-63.5%
Current Market
188%
CMMB's Return on Equity (-114%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CMMB announces earnings.

CMMB Return on Assets

Current Company
-88.5%
Current Industry
2.9%
CMMB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CMMB Return on Capital Employed

Current Company
-139.9%
Current Industry
19.5%
CMMB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CMMB vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CMMB$0.00-$24.15M-$24.22MN/AN/A
AEZS$4.50M-$16.38M-$16.55M-30.06%N/A
ERNA$68.00k-$19.93M-$21.68M-68.89%N/A
MBRX$0.00-$29.64M-$29.77MN/AN/A
CHRO$0.00-$6.86M-$7.38M-100.00%N/A
View Top Biotech Stocks

CMMB earnings dates

Next earnings date
May 9, 2024

Chemomab Therapeutics Earnings & Revenue FAQ

What were CMMB's earnings last quarter?

On Invalid Date, Chemomab Therapeutics (NASDAQ: CMMB) reported Q4 2023 earnings per share (EPS) of -$0.22, up 69.44% year over year. Total Chemomab Therapeutics earnings for the quarter were -$3.42 million. In the same quarter last year, Chemomab Therapeutics's earnings per share (EPS) was -$0.72.

If you're new to stock investing, here's how to buy Chemomab Therapeutics stock.

What was CMMB's earnings growth in the past year?

As of Q2 2024, Chemomab Therapeutics's earnings has grown year over year. Chemomab Therapeutics's earnings in the past year totalled -$24.22 million.

What is CMMB's earnings date?

Chemomab Therapeutics's earnings date is Invalid Date. Add CMMB to your watchlist to be reminded of CMMB's next earnings announcement.

What was CMMB's revenue last quarter?

On Invalid Date, Chemomab Therapeutics (NASDAQ: CMMB) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Chemomab Therapeutics's revenue was $0.00.

What was CMMB's revenue growth in the past year?

As of Q2 2024, Chemomab Therapeutics's revenue has grown null year over year. Chemomab Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.